SLC26A3 and inflammatory bowel disease: However, recent evidence suggests that the downregulation of SLC26A3 observed in the inflamed mucosa of IBD patients is just one component of a dysregulated differentiation process in the inflamed mucosa which prevents the full differentiation of absorptive enterocytes [116].